21st Nov 2022

Audited Final Results

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces its audited...

5th Oct 2022

Genedrive file US FDA Pre-Submission for the Genedrive® MT-RNR1 Product Range

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has...

26th Sep 2022

NICE to accelerate evaluation of the Genedrive® MT-RNR1 Test

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...